L-Carnitine
Also known as: Levocarnitine
A natural substance your body already makes that acts as a 'shuttle' to carry fat into your cells' energy factories (mitochondria) where it gets burned for fuel. Without enough carnitine, your body literally cannot burn long-chain fats for energy. One of the most popular and well-studied fat metabolism supplements available. Has FDA-approved forms for people with carnitine deficiency, and is widely available over the counter as a supplement.
L-Carnitine is a naturally occurring amino acid derivative that serves as the primary transport molecule for long-chain fatty acids into the mitochondria — the cellular organelles where fat is oxidized for energy. Without adequate carnitine, the body literally cannot burn long-chain fats efficiently, regardless of diet or exercise. The body synthesizes L-Carnitine from lysine and methionine in the liver and kidneys, and it is also obtained from dietary sources, particularly red meat and dairy.
The injectable form of L-Carnitine has gained significant attention because oral L-Carnitine has relatively poor bioavailability of only 15-25%. When injected intramuscularly or subcutaneously, L-Carnitine bypasses the digestive system entirely, providing near-100% bioavailability. The half-life of injectable L-Carnitine is approximately 2-3 hours, with effects on fat metabolism lasting throughout the day when combined with exercise. Injectable protocols typically use 500-1000 mg intramuscularly two to three times weekly.
L-Carnitine is one of the most well-studied supplements in existence, with FDA-approved prescription forms (Carnitor / levocarnitine) for primary carnitine deficiency and related conditions. Beyond fat metabolism, research has demonstrated benefits for cardiovascular health, exercise performance, recovery from training, and insulin sensitivity. The oral supplement form (500-2000 mg daily) remains widely popular and is available over the counter, though the lower bioavailability means higher doses are needed to achieve comparable tissue levels to the injectable form.
Dosage
| Weight | Suggested Dose |
|---|---|
| 60 kg / 130 lbs | 500-1500 mg oral daily or 500 mg IM 2-3x weekly |
| 75 kg / 165 lbs | 1000-2000 mg oral daily or 500-1000 mg IM 2-3x weekly |
| 90 kg / 200 lbs | 1000-2000 mg oral daily or 1000 mg IM 2-3x weekly |
| 115 kg / 250 lbs | 1500-2000 mg oral daily or 1000 mg IM 2-3x weekly |
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Oral (capsule, liquid) or intramuscular injection
Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Fat Transport
Sole carrier for long-chain fatty acids into mitochondria for energy production.
Exercise Performance
Modest improvements in exercise recovery and fat utilization during activity.
Metabolic Support
Buffers acyl-CoA/CoA ratio and supports branched-chain amino acid metabolism.
Mechanism of Action
L-Carnitine plays an indispensable role in cellular energy metabolism as the sole carrier molecule for transporting long-chain fatty acids (14+ carbons) across the inner mitochondrial membrane, which is otherwise impermeable to them. This transport system, known as the carnitine shuttle, is the rate-limiting step for fatty acid beta-oxidation — without carnitine, long-chain fats simply cannot be burned for energy.
The shuttle operates through a three-enzyme system. First, carnitine palmitoyltransferase I (CPT-I), located on the outer mitochondrial membrane, conjugates carnitine to a fatty acyl-CoA molecule, forming acylcarnitine. This acylcarnitine crosses the inner membrane via the carnitine-acylcarnitine translocase (CACT). Inside the mitochondrial matrix, carnitine palmitoyltransferase II (CPT-II) releases the fatty acid (as acyl-CoA) for beta-oxidation while regenerating free carnitine, which shuttles back out. Each cycle of beta-oxidation cleaves two carbons from the fatty acid chain, producing acetyl-CoA (which enters the citric acid cycle), FADH2, and NADH — generating substantial ATP.
Beyond fat transport, L-carnitine serves additional metabolic functions. It buffers the acyl-CoA/CoA ratio in cells, preventing toxic accumulation of acyl-CoA intermediates. It supports branched-chain amino acid metabolism and may improve mitochondrial function in aging tissues. In people with genuine carnitine deficiency (genetic or dialysis-related), supplementation produces dramatic improvements in energy and fat metabolism. However, in individuals with normal carnitine levels, supplementation has shown more modest effects, as the carnitine shuttle is rarely the limiting factor when carnitine is already adequate.
Regulatory Status
Available as dietary supplement (over the counter). Levocarnitine is FDA approved (Carnitor) for primary carnitine deficiency. Injectable form available through compounding pharmacies.
Risks & Safety
Common
nausea, diarrhea, stomach cramps, fishy body odour at high oral doses.
Serious
chronic high-dose oral use may produce TMAO, a compound linked to heart disease risk.
Rare
seizures in people with pre-existing seizure disorders.
Compare L-Carnitine With
Research Papers
30Published: February 5, 2026
AI Summary
Inflammatory cytokines like CXCL10 and FGF5 were linked to higher risk of thoracic aortic aneurysm, while CCL20 and CD40 were protective, with metabolites potentially mediating these effects. The findings point to new targets for preventing or treating this life-threatening condition.
Published: April 25, 2026
AI Summary
Aging beef 90 days increased L-carnitine, taurine, and glutathione compared to 5 days, while cooking reduced most bioactive compounds. Both aging and cooking should be considered when assessing the nutritional value of beef.
Published: January 4, 2025
AI Summary
Morinda officinalis oligosaccharides improved sperm motility in mice with chemically induced asthenozoospermia via the gut microbiome and IGF-1/PI3K/mTOR pathway. The work suggests a potential natural approach to male fertility.
Published: February 28, 2026
AI Summary
Tibetan sheep at higher altitudes had more carnitine derivatives and fewer peptides in their meat, with metabolism shaped by hypoxia and oxidative stress. The findings inform how altitude affects meat quality.
Published: February 22, 2026
AI Summary
Removing acyl-CoA binding protein from fat cells in mice did not alter whole-body energy metabolism. The results suggest this protein is not essential for systemic energy balance in adipose tissue.
Published: February 11, 2026
AI Summary
A mitochondrial protein that transports trimethyllysine controls carnitine production and the shift between fat and carbohydrate burning. Mice lacking it were cold-intolerant and resistant to weight loss from GLP-1 drugs, with implications for obesity treatment.
Published: December 3, 2026
AI Summary
The ketogenic diet was reviewed for contraindications, drug interactions, and side effects. The summary helps clinicians identify patients who should avoid or use caution with this diet.
Published: December 23, 2025
AI Summary
Blocking RACGAP1 made triple-negative breast cancer cells more sensitive to ferroptosis by altering fatty acid metabolism through CPT1A. The finding could lead to new combination treatments for this aggressive cancer.
Published: December 10, 2025
AI Summary
In chronic kidney disease, urinary choline, L-carnitine, and betaine correlated with megalin and tubular injury markers. The work suggests a link between gut-derived metabolites and kidney tubule damage.
Published: April 11, 2026
AI Summary
Protein stability in deep eutectic solvents depended on a critical hydration point where interfacial and bulk solvent properties were balanced. The finding could improve formulations for sensitive proteins.
Published: December 6, 2025
AI Summary
EPDR1 promoted gastric cancer growth by reprogramming fatty acid metabolism through STAT3 and CPT1A. Targeting this pathway could offer a new approach to treating gastric cancer.
Published: March 14, 2026
AI Summary
Chlorogenic acid and quercetin reduced food allergy responses in mice via the PPAR-gamma pathway. The polyphenols could support new treatments for food allergy.
Published: November 27, 2025
AI Summary
Heart function, inflammation, and mitochondrial damage were tracked in a mouse model of cirrhotic cardiomyopathy. The work clarifies how liver disease affects the heart and suggests therapeutic targets.
Published: October 25, 2025
AI Summary
Seasonal changes in metabolites of two Fucus seaweed species were mapped, with carnitine derivatives enriched in one species. The data support targeted use of these seaweeds for specific compounds.
Published: November 6, 2025
AI Summary
SGLT2 inhibitors, but not insulin, boosted kidney breakdown of branched-chain amino acids in a glycemic-independent way. The finding may explain some of the drugs' heart and kidney benefits.
Published: January 10, 2026
AI Summary
Liensinine improved cognitive function in mice with dementia by restoring neurotransmitters and reshaping gut bacteria and metabolites, including carnitine. The compound may act through the gut-brain axis.
Published: October 21, 2025
AI Summary
A PRMT1-STAT3-integrin axis was identified as a key driver of tacrolimus-induced kidney damage, with carnitine deficiency among the metabolic changes. The work suggests new targets for preventing transplant nephrotoxicity.
Published: November 30, 2025
AI Summary
Growth-restricted newborn lambs had altered heart metabolites within 24 hours, including lower lipid and carnitine levels. The findings may explain why these babies have a harder time adapting after birth.
Published: November 9, 2025
AI Summary
Immune cells, metabolites, and inflammatory cytokines were studied in IgA vasculitis to understand how they interact in this autoimmune disease.
Published: November 4, 2025
AI Summary
Bifidobacterium bifidum improved fatty liver in rats by boosting mitochondrial fat burning through the PPAR-alpha/PGC-1alpha/CPT1A pathway. The probiotic may offer a mitochondria-targeted strategy for fatty liver disease.
Published: February 28, 2026
AI Summary
Lauric acid from coconut oil increased fat breakdown and reduced leptin in mice and fat cells, partly via PPAR-gamma. The effects could support fat loss but may also affect appetite regulation.
Published: September 7, 2025
AI Summary
Expert consensus was reached on dosing, monitoring, and supplementation for hedgehog inhibitors in advanced basal cell carcinoma.
Published: January 12, 2026
AI Summary
Restoring mitophagy and carnitine metabolism via the XIAP-ULK1 axis reduced diabetic kidney disease in mice. Targeting this pathway could offer a new strategy for managing diabetic kidney damage.
Published: November 30, 2025
AI Summary
Omics technologies were reviewed for identifying obesity subtypes and biomarkers to guide precision treatment. DNA methylation at CPT1A and other loci may help stratify patients.
Published: October 30, 2025
AI Summary
A new enzyme was discovered that adds lipid groups to ribosomal peptides via tyrosine, expanding known ways that bacteria make lipopeptides.
Published: November 24, 2025
AI Summary
Combining the circadian compound nobiletin with tyrosine kinase inhibitors reversed advanced liver cancer in mice. The approach may improve outcomes for patients with clock-deficient tumors.
Published: September 30, 2025
AI Summary
Proteomics and metabolomics were used to study how semaglutide improves fatty liver in people with type 2 diabetes. The work aims to clarify molecular mechanisms of benefit.
Published: November 24, 2025
AI Summary
Bergenin reduced ulcerative colitis in mice by blocking gamma-delta T17 cell activation and fatty acid oxidation via miR-124-3p. The compound may offer a new approach to treating gut inflammation.
Published: October 7, 2025
AI Summary
APOE genotype influenced lipid profiles in brain blood vessels from Alzheimer's patients, with the epsilon4 allele linked to specific lipid changes. The findings may inform vascular contributions to dementia.
Published: November 1, 2025
AI Summary
L-carnitine added to standard RA drugs improved pain, stiffness, joint counts, and inflammation markers over 12 weeks. The supplement may support conventional treatment, though effects on STAT3 and TGF-beta need more study.
Frequently Asked Questions
What is L-Carnitine?
A natural substance your body already makes that acts as a 'shuttle' to carry fat into your cells' energy factories (mitochondria) where it gets burned for fuel. Without enough carnitine, your body literally cannot burn long-chain fats for energy. One of the most popular and well-studied fat metabolism supplements available. Has FDA-approved forms for people with carnitine deficiency, and is widely available over the counter as a supplement.
What is L-Carnitine used for?
A natural substance your body already makes that acts as a 'shuttle' to carry fat into your cells' energy factories (mitochondria) where it gets burned for fuel. Without enough carnitine, your body literally cannot burn long-chain fats for energy. One of the most popular and well-studied fat metabolism supplements available. Has FDA-approved forms for people with carnitine deficiency, and is widely available over the counter as a supplement.
What is the dosage for L-Carnitine?
Oral: 500-2000 mg once or twice daily. Injectable: 500-1000 mg intramuscular two or three times weekly. Clinical (Carnitor): 50-100 mg/kg/day oral for primary carnitine deficiency. Best combined with exercise for fat loss benefits.
What are the side effects of L-Carnitine?
Common: nausea, diarrhea, stomach cramps, fishy body odour at high oral doses. Serious: chronic high-dose oral use may produce TMAO, a compound linked to heart disease risk. Rare: seizures in people with pre-existing seizure disorders.
How does L-Carnitine work?
L-Carnitine plays an indispensable role in cellular energy metabolism as the sole carrier molecule for transporting long-chain fatty acids (14+ carbons) across the inner mitochondrial membrane, which is otherwise impermeable to them. This transport system, known as the carnitine shuttle, is the rate-limiting step for fatty acid beta-oxidation — without carnitine, long-chain fats simply cannot be burned for energy. The shuttle operates through a three-enzyme system. First, carnitine palmitoyltransferase I (CPT-I), located on the outer mitochondrial membrane, conjugates carnitine to a fatty acyl-CoA molecule, forming acylcarnitine. This acylcarnitine crosses the inner membrane via the carnitine-acylcarnitine translocase (CACT). Inside the mitochondrial matrix, carnitine palmitoyltransferase II (CPT-II) releases the fatty acid (as acyl-CoA) for beta-oxidation while regenerating free carnitine, which shuttles back out. Each cycle of beta-oxidation cleaves two carbons from the fatty acid chain, producing acetyl-CoA (which enters the citric acid cycle), FADH2, and NADH — generating substantial ATP. Beyond fat transport, L-carnitine serves additional metabolic functions. It buffers the acyl-CoA/CoA ratio in cells, preventing toxic accumulation of acyl-CoA intermediates. It supports branched-chain amino acid metabolism and may improve mitochondrial function in aging tissues. In people with genuine carnitine deficiency (genetic or dialysis-related), supplementation produces dramatic improvements in energy and fat metabolism. However, in individuals with normal carnitine levels, supplementation has shown more modest effects, as the carnitine shuttle is rarely the limiting factor when carnitine is already adequate.
How is L-Carnitine administered?
L-Carnitine is administered via oral (capsule, liquid) or intramuscular injection.
What is the half-life of L-Carnitine?
The half-life of L-Carnitine is 2-3 hours (injectable); oral bioavailability 15-25%.
Is L-Carnitine legal?
Available as dietary supplement (over the counter). Levocarnitine is FDA approved (Carnitor) for primary carnitine deficiency. Injectable form available through compounding pharmacies.
Related Peptides
5-Amino-1MQ
A pill that aims to switch fat cells from 'storage mode' to 'burning mode' by blocking an enzyme (NNMT) that is overactive in the fat tissue of overweight people. Not technically a peptide, but commonly sold alongside them. Unlike appetite suppressants, this targets the fat cells directly rather than making you eat less. The science is promising in lab studies, but there are no completed human trials yet.
Adipotide
An extreme experimental approach to fat loss — it physically destroys the blood vessels that feed fat tissue, starving fat cells until they die. Originally developed using anti-cancer technology at MD Anderson Cancer Center. While it did reduce fat in monkey studies, it also caused serious kidney damage, which has effectively stopped its development. Not available for human use.
AICAR
A natural compound that activates your cells' energy sensor — the same pathway that turns on during exercise. Mimics the metabolic effects of endurance exercise at the cellular level, helping with fat burning, glucose uptake, and building more mitochondria. Banned by WADA as a metabolic modulator after detection in professional cycling.
AOD-9604
A small piece of human growth hormone (amino acids 176-191) designed to keep only the fat-burning effects while removing the unwanted side effects of full growth hormone (like swelling and blood sugar problems). The idea is promising — burn fat without the downsides — but it failed to show significant weight loss in clinical trials. Still widely used in research and wellness clinics despite the weak clinical evidence.